Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation

Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation

Background. Primary cutaneous T-cell lymphomas are rare heterogeneous group of lymphoproliferative diseases characterized by primarily involving skin and subcutaneous adipose tissue. Half of these cases are mycosis fungoides (MF), for about 25% are cutaneous CD30+ lymphoproliferative diseases (CD30+...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liliya G. Gorenkova, Irena E. Belousova, Sergei K. Kravchenko, Alla M. Kovrigina, Yulia V. Sidorova, Nataliya V. Ryzhikova, Elena E. Lepik, Tatiana V. Shneyder
Formato: article
Lenguaje:RU
Publicado: IP Habib O.N. 2021
Materias:
primary t-cell lymphomas of the skin
targeted therapy
brentuximab vedotin
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/291b30b07346424bbc06b3d2d3266eb0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/291b30b07346424bbc06b3d2d3266eb0

Ejemplares similares